SCHEMBL10104450

SCHEMBL10104450

Cc1cc(CN2CCOCC2)c(Cl)c(C(F)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A13 Q16696 6/20 0.44
RORC P51449 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ATM Q13315 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CRHR1 P34998 2/20 0.43
PDE3B Q13370 2/20 0.43
PDE3A Q14432 2/20 0.43
TP53 P04637 1/20 0.42
CNR1 P21554 2/20 0.41
CNR2 P34972 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
HIF1A Q16665 1/20 0.40
EPAS1 Q99814 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10104470 0.87 KDM4E (0.46) MEN1KMT2AATMNPSR1CRHR1
SCHEMBL10104431 0.87 KDM4E (0.43) MEN1KMT2AATMNPSR1CRHR1
SCHEMBL10104460 0.86 KDM4E (0.43) MEN1KMT2AATMNPSR1CRHR1
SCHEMBL10104478 0.86 CNR1 (0.53) CYP2A13MEN1KMT2AATMNPSR1
SCHEMBL10104463 0.84 NR1H2 (0.53) MEN1KMT2AATMNPSR1MAPT
SCHEMBL10104436 0.80 RORC (0.46) RORCMEN1KMT2AATMNPSR1
SCHEMBL14515373 0.80 HSD17B10 (0.50) CYP2A13MEN1KMT2AATMNPSR1
SCHEMBL10104471 0.80 PDE3B (0.55) CYP2A13MEN1KMT2AATMNPSR1
SCHEMBL10104461 0.78 S1PR1 (0.37) RORCMEN1KMT2AATMNPSR1
SCHEMBL10104455 0.78 SCN9A (0.40) MEN1KMT2AATMNPSR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778929-B2 Substituted heteroaryl inhibitors of B-RAF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-15 US disclosed
US-8653087-B2 Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-02-18 US disclosed
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-19 US disclosed
US-20110312939-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312939-A1 NEW CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 CYP2A13 370/4885RORC 534/4885MEN1 254/4885
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS CCNT1, CCNA1, CCND1 CYP2A13 1507/4885RORC 2530/4885MEN1 1575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.